ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Kiniksa Pharmaceuticals (KNSA) Technical (Analysis) Reports Kiniksa Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Kiniksa Pharmaceuticals (KNSA)

Technical Analysis Report for NASDAQ stock KNSA Kiniksa Pharmaceuticals. Dated: 24 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock KNSA Kiniksa Pharmaceuticals then click here. or read Experts views on Kiniksa Pharmaceuticals or Forecast & share price targets of Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals Opened at 59.41 and Closed at: 59.13, which is -0.61% of previous session's close. It moved within a range of 58.54 and 61.12
The session was a Bearish session with an average volume of 1053600, which is 26.76% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Golden cross was found 4 days back on short term averages

A Golden cross was found 3 days back on mid term averages

Support for tomorrow is 57.55 and resistance for tomorrow is 60.13
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 58.07, 57.02 resistance for tomorrow's hourly charts is 60.65, 62.18

10 Day SMA for Kiniksa Pharmaceuticals (KNSA) is 54.25 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Kiniksa Pharmaceuticals (KNSA) is 51.61 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Kiniksa Pharmaceuticals (KNSA) is 52.02 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 48.99 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Kiniksa Pharmaceuticals is 44.43 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Kiniksa Pharmaceuticals is at 51.61 and 200 DMA is at 44.43, while 50 DMA and 100 DMA are at 52.02 and 48.99 respectively

Kiniksa Pharmaceuticals (KNSA) moving average of 20 SMA is at 51.61 and 20 EMA is at 53.54

Kiniksa Pharmaceuticals (KNSA) moving average of 50 SMA is at 52.02 and 50 EMA is at 51.82

Kiniksa Pharmaceuticals (KNSA) moving average of 100 SMA is at 48.99 and 100 EMA is at 49.22

Kiniksa Pharmaceuticals (KNSA) moving average of 200 SMA is at 44.43 and 200 EMA is at 44.33

Kiniksa Pharmaceuticals has performed better than Utah Medical in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!

Kiniksa Pharmaceuticals has performed better than United Therapeutics in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!

Kiniksa Pharmaceuticals has performed better than Sol Gel in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!

Natera Inc has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Natera Inc, about 13.92% more returns!

Endra Life has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Endra Life, about 2.92% more returns!

Moderna Inc has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Moderna Inc, about 12.78% more returns!

Kiniksa Pharmaceuticals has performed better than Ionis Pharmaceuticals in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!

Kiniksa Pharmaceuticals has performed better than Allogene Therapeutics in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!

Kiniksa Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!

Aquestive Therapeutics has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 10.38% more returns!

Kiniksa Pharmaceuticals has performed better than Equillium Inc in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!

Establishment Labs has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Establishment Labs, about 8.22% more returns!

Kiniksa Pharmaceuticals has performed better than Henry Schein in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!

Kiniksa Pharmaceuticals Technical analysis of indicators

Price action analysis of Kiniksa Pharmaceuticals (KNSA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Kiniksa Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Kiniksa Pharmaceuticals in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Kiniksa Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down

CCI has generated a buy signal for Kiniksa Pharmaceuticals in short term and BUY signal is strong.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Kiniksa Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 55.02 and Kiniksa Pharmaceuticals KNSA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Kiniksa Pharmaceuticals KNSA stock. Volume based technical analysis of Kiniksa Pharmaceuticals KNSA stock is negative.

Kiniksa Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock KNSA Kiniksa Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And KNSA Experts View which covers a lot of information including buying and selling signals

KNSA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Kiniksa Pharmaceuticals or View Candle Stick Charts here

Chart Kiniksa Pharmaceuticals (KNSA)  Technical (Analysis) Reports Kiniksa Pharmaceuticals [

Videos related to: Kiniksa Pharmaceuticals (KNSA) Technical (Analysis) Reports Kiniksa Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Kiniksa Pharmaceuticals (KNSA)  Technical (Analysis) Reports Kiniksa Pharmaceuticals [

 

Back to top